New strategy for severe Legionella pneumonia?

Abstract

Legionella pneumonia is among the top three of microbial causes of community–acquired pneumonia. During
the course of illness, respiratory failure, and even multiple organ failure may develop. Morbidity and mortality of
patients with Legionella pneumonia has been attributed to an imbalanced immune response yielding organ failure
and septic shock. In a case of severe Legionella pneumonia, the hemoperfusion with polymyxin B-immobilized
fiber column (PMX) drastically improved the respiratory and hemodynamic states, suggesting that PMX might
be a new strategy for severe Legionella pneumonia